India — Fishery/Seafood Products — Shrimp-Prawn

← back to leaderboard

India received 86 FDA import refusals in Shrimp-Prawn, part of Fishery/Seafood Products between 2023-Q4 and 2026-Q3. Volume peaked at 13 in 2025-Q1, with the trend falling sharply year-on-year. The most-cited issues are nitrofuran, vetdrugres, and filthy. No trade baseline is published for this commodity from India, so no per-$1B rate is shown here.

Of these, 86 were hazard refusals and 0 were paperwork refusals.

Exporting from India? Get an email when shipments from India are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

9 2023-Q4 2023-Q4: 9 12 2024-Q1 2024-Q1: 12 8 2024-Q2 2024-Q2: 8 5 2024-Q3 2024-Q3: 5 6 2024-Q4 2024-Q4: 6 13 2025-Q1 2025-Q1: 13 13 2025-Q2 2025-Q2: 13 8 2025-Q3 2025-Q3: 8 2 2025-Q4 2025-Q4: 2 6 2026-Q1 2026-Q1: 6 1 2026-Q2 2026-Q2: 1 3 2026-Q3 2026-Q3: 3

Recent rejections